JBM Healthcare CEO to Step Down; Successor Appointed

MT Newswires Live02-02

JBM (Healthcare) (HKG:2161) said chief executive officer Wong Yat Wai, Patrick, will resign, with effect from April 30, to pursue other career opportunities, according to a Jan. 30 Hong Kong bourse filing.

Shares of the drug company were down more than 1% in Monday's late morning trade.

The company said executive director and chairman Derek Sum Kwong Yip will be appointed chief executive on the same date.

Sum has more than 38 years of strategic and corporate management experience in the pharmaceutical industry, and is also chairman and chief executive officer of Jacobson Pharma (HKG:2633), the filing showed.

Following the change, Sum will serve as both chairman and chief executive.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment